Biodesix (BDSX) Shares Outstanding (Diluted Average) (2021 - 2026)

Biodesix has reported Shares Outstanding (Diluted Average) for 6 years, with the latest figure at $9.7 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 32.27% year-over-year to $9.7 million; the trailing twelve-month figure through Mar 2026 stood at $9.7 million (up 32.27% YoY), and the FY2025 full-year result was $7.6 million, up 16.71% from the prior year.
• Shares Outstanding (Diluted Average) for Q1 2026 stood at $9.7 million, up from $7.6 million in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $146.7 million in Q2 2025, with the low at $6.5 million in Q4 2024.
• Historically, Shares Outstanding (Diluted Average) has averaged $52.1 million across 5 years, with a median of $40.4 million in 2022.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Diluted Average) surged 1457.04% — and 2025, when it sank 92.49%.
• Biodesix's Shares Outstanding (Diluted Average) stood at $42.1 million in 2022, then surged by 95.03% to $82.1 million in 2023, then plunged by 92.12% to $6.5 million in 2024, then grew by 16.71% to $7.6 million in 2025, then rose by 27.88% to $9.7 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $9.7 million (Q1 2026), $7.6 million (Q4 2025), and $7.5 million (Q3 2025), per Business Quant data.